To Use DOACs in Obesity or Not?

Date August 12, 2020 Author By Eric Christianson Category Anticoagulation, Uncategorized

Direct-acting oral anticoagulants (DOACs; also called NOACs – novel oral anticoagulants) are an increasingly popular alternative to warfarin. Meanwhile, the number of obese patients requiring anticoagulation is also increasing. Because the landmark studies that established safety and efficacy for these agents specifically excluded patients with BMI ≥ 40 kg/m2 or weight > 120 kg, there […]